Skinny, Inc. Part 3: Body image in the age of Ozempic
The first episode of Skinny Inc. was all about the science behind GLP-1s, and the second episode was about the business, from the pharmaceutical companies who make GLP-1s to the insurance plans that may or may not cover it. Today, we’re exploring how the so-called “Ozempic era,” affects people’s mental health. First, business owner Maiyhet Burton tells us how using a GLP-1 has helped her body image. Globe health reporter Kelly Grant details how experts are split on the effect of GLP-1s on weight stigma, and psychotherapist Zoë Bisbing explains how the body positive movement helps her clients. Plus, Tigress Osborn, executive director of the National Association to Advance Fat Acceptance on why the popularity of GLP-1s shows how far we have to go with anti-fat discrimination, and Ary Mahraj and Emily Donahue from the National Eating Disorder Information Centre tell us how people with eating disorders may be impacted by the constant discussions about weight loss. Finally, Dr. Stephen Glazer, Medical Director for the Bariatric Surgical Program at Humber River Hospital in Toronto on how weight stigma can be internalized.
You May Also Like

Anchorage News Today | 2 Min News | The Daily News Now!
The Daily News Now!

Follow the Money
VSiN
Podcasts von Tichys Einblick
Tichys Einblick

Le journal d'Europe 1
Europe 1

Ox news daily
Ox News

ながら日経
ラジオNIKKEI

700 WLW On-Demand
WLW-AM (WLWAM)

Tech News Daily
brief.news

SBS Vietnamese - SBS Việt ngữ
SBS

WSJ What’s News
The Wall Street Journal
Community discussion